Li B - Search Results

1

Comparison of concurrent chemoradiotherapy with radiotherapy alone for locally advanced esophageal squamous cell cancer in elderly patients: A randomized, multicenter, phase II clinical trial.

Liu Y, Zheng Z, Li M, Zhang Y, Zhao F, Gong H, Lin H, Huang W, Chen X, Xu Z, Li X, Liu W, Cui Y, Zheng A, Li B. Liu Y, et al. Among authors: li x, li m, li b. Int J Cancer. 2022 Aug 15;151(4):607-615. doi: 10.1002/ijc.34030. Epub 2022 Apr 27. Int J Cancer. 2022. PMID: 35419831 Clinical Trial.

2

[Impact of PET/CT on precise radiotherapy planning for non-small cell lung cancer].

Gong HY, Yu JM, Fu Z, Li BS, Li JB, Liu TH. Gong HY, et al. Zhonghua Zhong Liu Za Zhi. 2006 Jan;28(1):54-7. Zhonghua Zhong Liu Za Zhi. 2006. PMID: 16737623 Chinese.

3

[Progress of proteomics in diagnosis and treatments of lung cancer].

Huang W, Li BS. Huang W, et al. Zhonghua Jie He He Hu Xi Za Zhi. 2008 Dec;31(12):926-7. Zhonghua Jie He He Hu Xi Za Zhi. 2008. PMID: 19134411 Review. Chinese. No abstract available.

4

Phase I study of concurrent selective lymph node late course accelerated hyper-fractionated radiotherapy and Capecitabine, Cisplatin for locally advanced esophageal squamous cell carcinoma.

Li BS, Zhou T, Wang ZT, Li HS, Sun HF, Zhang ZC, Lin HQ, Wei YM, Gong HY, Huang W, Yi Y, Wang LY. Li BS, et al. Radiother Oncol. 2009 Dec;93(3):458-61. doi: 10.1016/j.radonc.2009.08.002. Epub 2009 Sep 3. Radiother Oncol. 2009. PMID: 19733411 Clinical Trial.

5

Clinical and dosimetric risk factors of acute esophagitis in patients treated with 3-dimensional conformal radiotherapy for non-small-cell lung cancer.

Zhang ZC, Xu J, Li BS, Zhou T, Lu J, Wang ZT, Li HS, Sun HF, Zhu J, Yu JM. Zhang ZC, et al. Am J Clin Oncol. 2010 Jun;33(3):271-5. doi: 10.1097/COC.0b013e3181a879e0. Am J Clin Oncol. 2010. PMID: 19823071

6

CYFRA21-1 and CEA are useful markers for predicting the sensitivity to chemoradiotherapy of esophageal squamous cell carcinoma.

Yi Y, Li B, Wang Z, Sun H, Gong H, Zhang Z. Yi Y, et al. Among authors: li b. Biomarkers. 2009 Nov;14(7):480-5. doi: 10.3109/13547500903180265. Biomarkers. 2009. PMID: 19863186

7

[Impact of the pattern of lymph node metastasis on the clinical target volume in radiotherapy for thoracic esophageal squamous cell carcinoma].

Huang W, Li BS, Gong HY, Fan M, Sun HF, Zhou T, Liu XB. Huang W, et al. Zhonghua Zhong Liu Za Zhi. 2010 Mar;32(3):225-8. Zhonghua Zhong Liu Za Zhi. 2010. PMID: 20450594 Chinese.

8

Phase I study of concurrent selective lymph node late course accelerated hyper-fractionated radiotherapy and pemetrexed, cisplatin for locally advanced esophageal squamous cell carcinoma.

Li BS, Gong HY, Huang W, Yi Y, Zhang ZC, Li HS, Wang ZT, Yu JM. Li BS, et al. Dis Esophagus. 2011 May;24(4):251-7. doi: 10.1111/j.1442-2050.2010.01130.x. Epub 2010 Nov 12. Dis Esophagus. 2011. PMID: 21073623 Clinical Trial.

9

[Role of (18)F-FDG PET for therapeutic monitoring in non-small-cell lung cancer].

Huang W, Wang J, Li BS. Huang W, et al. Zhonghua Jie He He Hu Xi Za Zhi. 2010 Nov;33(11):855-7. Zhonghua Jie He He Hu Xi Za Zhi. 2010. PMID: 21211376 Review. Chinese. No abstract available.

10

Phase I study of pemetrexed, cisplatin, and concurrent radiotherapy in patients with locally advanced non-small cell lung cancer.

Li BS, Gong HY, Huang W, Yi Y, Yu JM, Wang ZT, Zhang ZC, Sun HF, Li HS, Wang LY. Li BS, et al. Am J Clin Oncol. 2012 Apr;35(2):115-9. doi: 10.1097/COC.0b013e318209ab93. Am J Clin Oncol. 2012. PMID: 21555933 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46,523 results

Search Page

Filters